You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
A simple assay system for rapid detection of circulating tumor cells
SBC: TELOVISION, LLC Topic: NCIDESCRIPTION provided by applicant Metastasis or dissemination of primary tumor cells is the major cause of mortality in cancer patients Circulating tumor cells CTCs in the bloodstream are key players in the establishment of metastatic tumors Recent studies demonstrated that the number of CTCs present in patient blood directly correlate with cancer progression recurrence and survival rate ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Peptide Antibiotic Nucleic Acids
SBC: NUBAD, LLC Topic: NIAIDDESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
New heterocyclic inhibitors of filoviruses
SBC: MICROBIOTIX, INC. Topic: HDESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
New small molecule inhibitors of arenaviruses
SBC: MICROBIOTIX, INC. Topic: RDESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas
SBC: Tymora Analytical Operations, LLC Topic: 300DESCRIPTION provided by applicant Mass spectrometry based proteomics is an emerging technology that has seen possible applications everywhere The technique can potentially use one drop of our blood to reveal onset and progress of diseases Current Randamp D using plasma serum proteome sample sets however is severely limited by the high complexity and dynamic range of protein concentrations ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Universal amplifier system for high-fidelity multi-modal biosignal recordings
SBC: REFER2INPUT, LLC Topic: 213DESCRIPTION provided by applicant The measurement monitoring and use of bioelectric signals has evolved from the measurement of the electrical activity of the heart to encompass tissues ranging from cardiac skeletal and smooth muscles to brain and peripheral nerve tissues Together with this development has been the evolution of specialized equipment to capture and interpret these minute sig ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Methodology for Attrition Evaluation of Oxygen Carriers in Chemical Looping Systems
SBC: ENVERGEX LLC Topic: 11dThis Small Business Innovation Research (STTR) project targets the development of novel methodology for the evaluation of a wide range of oxygen carriers, in particular, their attrition resistance, under conditions that broadly account for the process requirements of coal-based chemical looping systems. Existing test protocols and procedures for the evaluation of granular materials do not accurate ...
STTR Phase I 2014 Department of Energy -
Ionomer Dispersion Impact on Advanced Fuel Cell and Electrolyzer Performance and Durability
SBC: Giner, Inc. Topic: 09bThe ionomer dispersion technology invented at LANL has demonstrated great potential to significantly improve the lifetime of proton exchange membrane (PEM) fuel cells via accelerated stress tests. However, more validation and improvements are needed to make this technology commercially viable for PEM fuel cell-based hydrogen vehicles. The overall project is to further improve and validate this ion ...
STTR Phase I 2014 Department of Energy -
Automated process for the fabrication of highly customized thermally insulated cladding systems
SBC: Polycel Inc Topic: 03bAdding thermal insulation to existing building envelopes can be an effective way of reducing building energy use. While most thermal insulation materials are affordable, the cost of installing thermal insulation into existing buildings can be expensive. Real facades are also characterized by many unique elements that affect their rated thermal performance, such as corners, windows, d ...
STTR Phase I 2014 Department of Energy -
Development of small near-infrared laser system capable of improving immune respo
SBC: SEMINEX CORPORATION Topic: NIAIDDESCRIPTION (provided by applicant): The broad and long-term objective of this project is to amplify the effectiveness of vaccines without the use of chemical or biological adjuvants. We will address this objective by demonstrating the feasibility for small laser- based devices to enhance responses to intradermal vaccination. A number of investigators have shown that a promising new way to make va ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health